TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/22/23 17:18 | 11/21/23 | NEXI | Neximmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Roemer Alan S. | MD | D | S.m | -16 | 2.05 | 0 | -8 | -100 | 0 | D | |||||||||||||||
8/18/22 16:08 | 8/16/22 | INAB | In8Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Roemer Alan S. | NY | D | P | 50 | 1.90 | 0 | 26 | 89 | 56 | D | |||||||||||||||
12/22/21 17:00 | 12/21/21 | NEXI | Neximmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Roemer Alan S. | MD | D | M.d | 246 | 3.63 | 0 | 68 | 53 | 196 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |